Efficacy and safety of gyejigachulbutang on patient with facet joint syndrome treated by posterior medial branch block - pilot study

Not Applicable

Recruiting

• Conditions: Diseases of the musculo-skeletal system and connective tissue

• Registration Number: KCT0001379
• Lead Sponsor: Comprehensive and Integrative Medical Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 March 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

1. Facet joint syndrome patients, shows minimum 50% decrease of pain after posterior medial branch block as diagnotic purpose.
2. Age 20 to 75 years.
3. Ability to comprehend or express oneself in the Korean language
4. Follow-up possible during the clinical trial
5. Written informed consent voluntarily

Exclusion Criteria

1. All contraindications to corticosteroid injection (e.g., insulin-dependent diabetes)
2. Senile dementia, impaired cognitive function or other cerebral disease, severe psychiatric or psychological disorders
3. Alcohol/drug abuse
4. Significant renal or hepatic disease
5. Pregnant, lactating or planning a pregnancy
6. suspected severe heart disease in ECG
7. Refusal to participate in the trial or to provide informed consent
8. An individual deemed to be ineligible by a physician

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Visual Analogue Scale(VAS);Painvision

Secondary Outcome Measures

Name	Time	Method
Short form McGill pain questionnaire(SF-MPQ);Oswestry Disability Index(ODI)